Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03250234 · ClinicalTrials.gov registry record · NA

Carbohydrate Availability and microRNA Expression

A NA study, sponsored by United States Army Research Institute of Environmental Medicine.

Completed
Registry status
NA
Development phase
12
Enrollment target

NCT03250234 is a NA study that has completed, run by United States Army Research Institute of Environmental Medicine. The registered enrollment target is 12 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03250234, a NA study, has completed, sponsored by United States Army Research Institute of Environmental Medicine.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

This investigation will examine the impact of skeletal muscle glycogen stores on skeletal muscle and circulating microRNA expression and exogenous carbohydrate oxidation. Primary Objective Determine the influence of carbohydrate availability (e.g., glycogen depletion and repletion) on skeletal muscle microRNA expression, and if changes in circulating microRNA are reflective of changes in skeletal muscle microRNA. Secondary Objective Determine how initiation of exercise with adequate or low glycogen stores effects exogenous carbohydrate efficiency.

Interventions

  • OTHER Adequate Carbohydrate
  • OTHER Low Carbohydrate

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2017-08-01
Est. Completion 2018-05-03
Phase NA

What the Registry Record Tells You About NCT03250234

The ClinicalTrials.gov registry entry for NCT03250234 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United States Army Research Institute of Environmental Medicine, which has 59 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Adequate Carbohydrate is the first listed.

NCT03250234 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03250234 about?

NCT03250234 is a clinical study titled "Carbohydrate Availability and microRNA Expression". This investigation will examine the impact of skeletal muscle glycogen stores on skeletal muscle and circulating microRNA expression and exogenous carbohydrate oxidation. Primary Objective Determine the influence of carbohydrate availability (e.g., glycogen depletion and repletion) on skeletal musc...

What is the current status of trial NCT03250234?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2017-08-01. Estimated completion is 2018-05-03.

What interventions are being tested in trial NCT03250234?

The interventions under investigation include: Adequate Carbohydrate (OTHER), Low Carbohydrate (OTHER).

Who is sponsoring clinical trial NCT03250234?

This trial is sponsored by United States Army Research Institute of Environmental Medicine, which has 59 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.